FC
IONS icon

FIC Capital’s Ionis Pharmaceuticals IONS Stock Holding History

FIC Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$978K Hold
19,290
– – 0.37% 63
2017
Q2 		$981K Sell
19,290
-650
-3% -$30.3K 0.4% 64
2017
Q1 		$802K Sell
19,940
-6,790
-25% -$305K 0.36% 68
2016
Q4 		$1.28M Hold
26,730
– – 0.64% 50
2016
Q3 		$979K Hold
26,730
– – 0.44% 62
2016
Q2 		$623K Hold
26,730
– – 0.3% 73
2016
Q1 		$1.08M Hold
26,730
– – 0.52% 55
2015
Q4 		$1.66M Sell
26,730
-450
-2% -$24.3K 0.73% 42
2015
Q3 		$1.1M Hold
27,180
– – 0.52% 55
2015
Q2 		$1.56M Sell
27,180
-1,115
-4% -$70.9K 0.62% 51
2015
Q1 		$1.8M Buy
28,295
+150
+0.5% +$10.2K 0.69% 45
2014
Q4 		$1.74M Hold
28,145
– – 0.67% 48
2014
Q3 		$1.09M Buy
28,145
+900
+3% +$31.9K 0.44% 79
2014
Q2 		$939K Buy
27,245
+65
+0.2% +$2.05K 0.37% 87
2014
Q1 		$1.17M Buy
27,180
+650
+2% +$31.5K 0.48% 74
2013
Q4 		$1.06M Buy
26,530
+25
+0.1% +$891 0.47% 81
2013
Q3 		$995K Buy
26,505
+1,825
+7% +$54.5K 0.51% 80
2013
Q2 		$663K Buy
+24,680
New +$525K 0.42% 75

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

FIC Capital's IONS Position: Q3 2017 in Review

FIC Capital held its Ionis Pharmaceuticals (IONS) position steady in Q3 2017 at 19,290 shares worth $978K. The position accounts for 0.37% of the portfolio, ranked #63.

FIC Capital first reported a position in IONS in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.8M in Q1 2015. 301 funds tracked by Wall St. Rank hold IONS as of Q3 2017.

  • FIC Capital held 19,290 shares of Ionis Pharmaceuticals worth $978K as of Q3 2017.
  • FIC Capital left its Ionis Pharmaceuticals share count unchanged in Q3 2017.
  • Ionis Pharmaceuticals made up 0.37% of FIC Capital's portfolio in Q3 2017, its #63 holding.
  • FIC Capital first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 18 quarters since.
  • FIC Capital's Ionis Pharmaceuticals position peaked at $1.8M in Q1 2015.
  • 301 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2017.

Based on FIC Capital's 13F filing for Q3 2017, filed 14 Nov 2017.